The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(Z)-7-[(1R,2S,5R)-2-(4a,5-Dihydro-quinoline-8-sulfonylamino)-5-fluoro-cyclopentyl]-hept-5-enoic acid ID: ALA3706741
PubChem CID: 122197353
Max Phase: Preclinical
Molecular Formula: C21H25FN2O4S
Molecular Weight: 420.51
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)CCC/C=C\C[C@H]1[C@H](F)CC[C@@H]1NS(=O)(=O)c1cccc2cccnc12
Standard InChI: InChI=1S/C21H25FN2O4S/c22-17-12-13-18(16(17)9-3-1-2-4-11-20(25)26)24-29(27,28)19-10-5-7-15-8-6-14-23-21(15)19/h1,3,5-8,10,14,16-18,24H,2,4,9,11-13H2,(H,25,26)/b3-1-/t16-,17+,18-/m0/s1
Standard InChI Key: WQRIRZONRYDKCT-ALVNHBQLSA-N
Molfile:
RDKit 2D
29 31 0 0 1 0 0 0 0 0999 V2000
4.4516 -4.2143 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.2761 -4.0768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8008 -4.7140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6271 -4.3475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5260 -5.4885 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1024 -3.6979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3897 -2.9275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6140 -4.9388 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3142 -3.3897 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5635 -3.3106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6129 -4.5765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9656 0.7621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7276 -2.4153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3755 -3.1649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2654 -3.6604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1376 -5.2095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4986 1.3867 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0507 -6.1215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8627 -5.9757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0530 -2.8775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3892 -1.8906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1268 -1.1119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7526 -1.5866 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.1618 0.9078 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1893 -2.7026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9002 -3.8020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2404 -0.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3148 -0.9536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0482 -0.1749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 2 0
4 1 1 0
5 3 1 0
6 4 1 1
7 6 1 0
8 1 2 0
9 1 2 0
10 2 1 0
11 3 1 0
12 27 1 0
13 7 1 0
14 10 2 0
15 6 1 0
16 11 1 0
17 12 2 0
18 5 2 0
19 16 2 0
20 15 1 0
21 25 1 0
22 21 2 0
13 23 1 1
24 12 1 0
7 25 1 6
26 14 1 0
27 29 1 0
28 22 1 0
29 28 1 0
13 20 1 0
26 11 2 0
18 19 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 420.51Molecular Weight (Monoisotopic): 420.1519AlogP: 3.83#Rotatable Bonds: 9Polar Surface Area: 96.36Molecular Species: ACIDHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.58CX Basic pKa: 0.48CX LogP: 3.21CX LogD: 0.46Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.47Np Likeness Score: -0.19
References 1. Klar U, Kuhnke J, Pletsch A, Rehwinkel H, Schreyer R. (1995) Novel prostanoid thromboxane A2 antagonists, 5 (12): [10.1016/0960-894X(95)00199-4 ]